Concepedia

Ori Braitbard

OB

Statistics

Publications

13

Citations

430

H-Index

13

Active since

2006

Affiliations

Hebrew University of Jerusalem(Current)

Fondazione Pisa

Ori Braitbard is an author at Hebrew University of Jerusalem specializing in medicine, oncology, and cancer pharmacology.

ORCID

Publications per year

2006–2020

13

Publications

13

Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents

Lilia Reytman, Ori Braitbard, Jacob Hochman et al. · Inorganic Chemistry · 2015 · 61 citations

, , +14

Cytotoxic Salan–Titanium(IV) Complexes: High Activity Toward a Range of Sensitive and Drug‐Resistant Cell Lines, and Mechanistic Insights

Cesar M. Manna, Ori Braitbard, Jacob Hochman et al. · ChemMedChem · 2012 · 53 citations

, , +13

Highly cytotoxic vanadium(v) complexes of salan ligands; insights on the role of hydrolysis

Lilia Reytman, Ori Braitbard, Edit Y. Tshuva · Dalton Transactions · 2012 · 49 citations

, , +15

Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents

Sigalit Meker, Ori Braitbard, Matthew D. Hall et al. · Chemistry - A European Journal · 2016 · 44 citations

, , +16

Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity

Maya Miller, Ori Braitbard, Jacob Hochman et al. · Journal of Inorganic Biochemistry · 2016 · 33 citations

, , +13

1–5 of 13